Precipio Signs Additional Major HemeScreen™ Customer
06 déc. 2022 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced a 4-year agreement with a new customer to bring HemeScreen™...